Episode 1358 • • 25:08 - 27:57
1358: Media Liescape
COVID-19 Treatments, AT-527 Pill and Ivermectin Studies
Oxford University has begun testing the anti-parasitic drug ivermectin as a potential COVID-19 treatment for non-hospital settings. This follows a period where the drug was largely dismissed by the medical establishment. Additionally, a new antiviral pill, AT-527, which was originally developed for Hepatitis C, is currently in late-stage clinical trials for use against the coronavirus.